Suppr超能文献

特发性肺纤维化的营养评估:一项前瞻性多中心研究。

Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study.

作者信息

Faverio Paola, Fumagalli Alessia, Conti Sara, Madotto Fabiana, Bini Francesco, Harari Sergio, Mondoni Michele, Oggionni Tiberio, Barisione Emanuela, Ceruti Paolo, Papetti Maria Chiara, Bodini Bruno Dino, Caminati Antonella, Valentino Angela, Centanni Stefano, Noè Donatella, Della Zoppa Matteo, Crotti Silvia, Grosso Marco, Sukkar Samir Giuseppe, Modina Denise, Andreoli Marco, Nicali Roberta, Suigo Giulia, De Giacomi Federica, Busnelli Sara, Cattaneo Elena, Mantovani Lorenzo Giovanni, Cesana Giancarlo, Pesci Alberto, Luppi Fabrizio

机构信息

Respiratory Unit, School of Medicine and Surgery, University of Milano Bicocca, San Gerardo Hospital, ASST Monza, Monza, Italy.

These authors contributed equally.

出版信息

ERJ Open Res. 2022 Mar 7;8(1). doi: 10.1183/23120541.00443-2021. eCollection 2022 Jan.

Abstract

BACKGROUND

Nutritional status impacts quality of life and prognosis of patients with respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack of studies performing an extensive nutritional assessment of IPF patients. This study aimed to investigate the nutritional status and to identify nutritional phenotypes in a cohort of IPF patients at diagnosis.

METHODS

Patients underwent a thorough pulmonary and nutritional evaluation including questionnaires on nutritional status, and physical activity, anthropometry, body impedance, dynamometry, 4-m gait speed and blood tests.

RESULTS

90 IPF patients (78.9% males, mean age 72.7 years) were enrolled. The majority of patients were classified as Gender-Age-Physiology Index stage 2 (47, 52.2%) with an inactive lifestyle according to International Physical Activity Questionnaire score (39, 43.3%), and had mean forced vital capacity and diffusing capacity for carbon monoxide 86.5% and 54.2%, respectively. In regards to nutritional phenotypes, the majority of patients were normally nourished (67.8%, 95% CI 58.6-77.7%), followed by non-sarcopenic obese (25.3%, 95% CI 16.1-35.2%), sarcopenic (4.6%, 95% CI 0.0-14.5%) and sarcopenic obese (2.3%, 95% CI 0.0-12.2%). Among the normally nourished, 49.2% showed early signs of nutritional and physical performance alterations, including body mass index ≥30 kg·m in 4.3%, history of weight loss ≥5% in 11.9%, and reduction of gait speed and hand grip strength in 11.9% and 35.6%, respectively. Low vitamin D values were observed in 56.3% of cases.

CONCLUSIONS

IPF patients at diagnosis are mainly normally nourished and obese, but early signs of nutritional and physical performance impairment can already be identified at this stage.

摘要

背景

营养状况会影响包括特发性肺纤维化(IPF)在内的呼吸系统疾病患者的生活质量和预后。然而,缺乏对IPF患者进行全面营养评估的研究。本研究旨在调查一组IPF患者在诊断时的营养状况并确定营养表型。

方法

患者接受了全面的肺部和营养评估,包括关于营养状况、身体活动的问卷调查,人体测量、身体阻抗、握力测试、4米步速测试和血液检查。

结果

纳入了90例IPF患者(男性占78.9%,平均年龄72.7岁)。根据国际体力活动问卷评分,大多数患者被归类为性别-年龄-生理指数2期(47例,52.2%),生活方式不活跃(39例,43.3%),平均用力肺活量和一氧化碳弥散量分别为86.5%和54.2%。关于营养表型,大多数患者营养正常(67.8%,95%可信区间58.6 - 77.7%),其次是非肌肉减少性肥胖(25.3%,95%可信区间16.1 - 35.2%)、肌肉减少症(4.6%,95%可信区间0.0 - 14.5%)和肌肉减少性肥胖(2.3%,95%可信区间0.0 - 12.2%)。在营养正常的患者中,49.2%表现出营养和身体机能改变的早期迹象,包括4.3%的体重指数≥30kg·m²,11.9%的体重减轻史≥5%,以及11.9%和35.6%的步速和握力下降。56.3%的病例维生素D值较低。

结论

IPF患者在诊断时主要营养正常且肥胖,但在此阶段已可识别出营养和身体机能损害的早期迹象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb2/8899499/9bcb7403b310/00443-2021.01.jpg

相似文献

1
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study.
ERJ Open Res. 2022 Mar 7;8(1). doi: 10.1183/23120541.00443-2021. eCollection 2022 Jan.
4
Physical activity in daily life in patients with idiopathic pulmonary fibrosis.
Respir Investig. 2018 Jan;56(1):57-63. doi: 10.1016/j.resinv.2017.09.004. Epub 2017 Oct 23.
6
Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.
BMC Pulm Med. 2021 Feb 5;21(1):51. doi: 10.1186/s12890-021-01418-5.
7
Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Respirology. 2018 Aug;23(8):764-770. doi: 10.1111/resp.13294. Epub 2018 Mar 24.
8
Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
Ann Am Thorac Soc. 2020 Nov;17(11):1413-1423. doi: 10.1513/AnnalsATS.201912-880OC.

引用本文的文献

1
Nutritional insights into pulmonary fibrosis: a comprehensive review on the impact of vitamins.
Front Nutr. 2025 Apr 11;12:1525408. doi: 10.3389/fnut.2025.1525408. eCollection 2025.
4
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
5
Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study.
Front Endocrinol (Lausanne). 2024 Jan 8;14:1321576. doi: 10.3389/fendo.2023.1321576. eCollection 2023.
8
Vitamin D and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study.
BMC Pulm Med. 2023 Aug 23;23(1):309. doi: 10.1186/s12890-023-02589-z.
9
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis.
Eur Respir Rev. 2023 Jul 12;32(169). doi: 10.1183/16000617.0165-2022. Print 2023 Sep 30.
10
Protective effect of BB536 against nausea caused by pirfenidone in a mouse model of pellagra.
Biosci Microbiota Food Health. 2023;42(3):195-202. doi: 10.12938/bmfh.2022-042. Epub 2023 Mar 9.

本文引用的文献

1
Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.
BMC Pulm Med. 2021 Feb 5;21(1):51. doi: 10.1186/s12890-021-01418-5.
2
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis.
Respir Res. 2020 Nov 25;21(1):312. doi: 10.1186/s12931-020-01528-4.
3
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Respirology. 2021 Feb;26(2):171-179. doi: 10.1111/resp.13943. Epub 2020 Sep 23.
7
Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis.
Pulm Pharmacol Ther. 2019 Apr;55:17-24. doi: 10.1016/j.pupt.2019.01.003. Epub 2019 Jan 16.
8
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study.
Eur Respir J. 2019 Feb 7;53(2). doi: 10.1183/13993003.01186-2018. Print 2019 Feb.
9
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
10
The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients.
Respiration. 2018;96(4):338-347. doi: 10.1159/000490355. Epub 2018 Aug 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验